Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.
According to new research published in Clinical and Translational Immunology, a new cancer vaccine is ready for human trials following its success in preclinical studies.
Regular testing for hepatitis C virus has proven more effective than targeted testing.
Pharmacy Times® interviewed Tim Safley, program director of the Accreditation Commission for Health Care (ACHC), and Jon Pritchett, program director of ACHC, on the value of specialty pharmacy and LTC accreditation for pharmacies.
National Association of Specialty Pharmacy Releases Agenda for Fifth Annual Specialty Pharmacy Law Conference
The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience.
Early and frequent screenings for childhood cancer survivors could cut breast cancer mortality by well over half.
Pharmacy Times® interviewed Tim Safley and Jon Pritchett of ACHC on evaluating the opportunities for long-term care (LTC) pharmacies in relation to specialty pharmacy accreditation.
Key opinion leaders discuss which characteristics of oral therapies need to be managed by pharmacists.
A potential correlation between processed food and breast cancer has been discovered.
Multiple pharmacies recently received letters from ESI stating that on behalf of TRICARE and the Defense Health Agency, ESI was recouping money for compound drug claims submitted in 2015.
Timely Antiviral Administration for Influenza Is Critical to Reduce Its Clinical and Economic Burden
Pharmacists must be able to identify populations that are at high risk for influenza complications.
Relapsed or Refractory Follicular and Mantle Cell Lymphomas: Pharmacist-Driven Strategies to Optimize Patient Management
At the completion of this activity, the participant will be able to determine appropriate treatment options for a patient with relapsed or refractory FL or MCL.